THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

“The existing situation has exposed some structural weaknesses in the EU’s medicines provide chain as well as a significant dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She suggested that provide chain challenges be resolved in an EU pharmaceutical technique anticipated to be released